Findings

What do systematic reviews say?

2,359 questions · 2,491 findings · 249 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 696 · 27.9%GRADE not reported 213 · 8.6%Very low 611 · 24.5%Low 595 · 23.9%Moderate 315 · 12.6%High 61 · 2.4%

Yoga vs no specific active intervention

Quality of life (IIQ scores) · women with either stress‐predominant or urge‐predominant urinary incontinence

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Yoga vs no specific active intervention

Number of micturitions (daily) at short term (6 weeks) · women with either stress‐predominant or urge‐predominant urinary incontinence

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Yoga vs no specific active intervention

Incontinence · women with either stress‐predominant or urge‐predominant urinary incontinence

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Yoga vs no specific active intervention

Bothersomeness of symptoms at short term (6 weeks) Measured by Urogenital Distress Inventory 6 (UDI‐6) (lower = better) · women with either stress‐predominant or urge‐predominant urinary incontinence

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Yoga vs no specific active intervention

Adverse effects at short term (6 weeks) · women with either stress‐predominant or urge‐predominant urinary incontinence

It is very uncertain whether yoga changes adverse effects at short term (6 weeks) compared with no specific active intervention (very low certainty).

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
RD 0
1 study · 18 participants
Very low

Yoga vs an active intervention

Number of women cured · women with urge‐predominant urinary incontinence

The review found no eligible studies for this question.

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs an active intervention

Number of women who report cure or improvement of urinary incontinence at short term (8 weeks) · women with urge‐predominant urinary incontinence

It is very uncertain whether yoga changes number of women who report cure or improvement of urinary… compared with an active intervention (very low certainty).

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
RR 0.09 [0.01, 1.43]
1 study · 24 participants
Very low

Antidepressants vs placebo

Anxiety · people with inflammatory bowel disease

2 findings from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Low
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Antidepressants vs placebo

Depression at 12 weeks · people with inflammatory bowel disease

1 finding from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Low

Antidepressants vs placebo

Depression at 12 months · people with inflammatory bowel disease

1 finding from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Antidepressants vs placebo

Adverse events at 12 months · people with inflammatory bowel disease

Antidepressants showed no clear difference in adverse events at 12 months compared with placebo (low certainty).

1 finding from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
RR 2.29 [0.78, 6.73]
1 study · 26 participants
Low

Antidepressants vs placebo

Quality of life · people with inflammatory bowel disease

1 finding from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 70 participants
Low

Antidepressants vs placebo

Pain · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antidepressants vs placebo

Maintenance of remission · people with inflammatory bowel disease

Antidepressants showed no clear difference in maintenance of remission at 12 months compared with placebo (low certainty).

1 finding from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
RR 0.96 [0.55, 1.69]
1 study · 26 participants
Low

Antidepressants vs placebo

Endoscopic relapse · people with inflammatory bowel disease

It is very uncertain whether antidepressants changes endoscopic relapse at 12 months compared with placebo (very low certainty).

1 finding from 1 review

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
RR 0.14 [0.01, 2.65]
1 study · 60 participants
Very low

Antibiotics vs placebo

Failure to induce clinical remission at end of study · Patients with active Crohn's disease

Antibiotic leads to lower failure to enter clinical remission compared with placebo (high certainty).

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
RR 0.86 [0.76, 0.98]
7 studies · 773 participants
High

Antibiotic with anti‐TNF vs placebo with anti‐TNF

Failure to achieve clinical response or remission · Patients with active Crohn's disease

Antibiotic with anti‐TNF showed no clear difference in failure to achieve clinical response or remission compared with placebo with anti‐TNF (low certainty).

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
RR 0.57 [0.29, 1.1]
2 studies · 100 participants
Low

Antibiotic with anti‐TNF vs placebo with anti‐TNF

Failure to maintain endoscopic remission · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antibiotic with anti‐TNF vs placebo with anti‐TNF

Adverse events · Patients with active Crohn's disease

Antibiotic with anti‐TNF showed no clear difference in adverse events compared with placebo with anti‐TNF (moderate certainty).

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
RR 0.93 [0.76, 1.12]
2 studies · 100 participants
Moderate

Antibiotic with anti‐TNF vs placebo with anti‐TNF

Serious adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found